SuperAgers Study and Cellular Rejuvenation Research Highlight Aging Advances

Researchers at the University of Chicago and affiliated U.S. centers studied 142 individuals aged 80‑90 with exceptionally preserved memory—so‑called SuperAgers—against 89 average‑cognitive peers. Published in Alzheimer’s Research & Therapy, the work suggests protective mechanisms beyond low genetic risk for Alzheimer’s disease. Director Emily Rogalski noted the possibility of identifying SuperAgers with genetic tests rather than extensive cognitive exams.

In Argentina, biologist Eduardo Arzt, director of the Institute for Biomedical Research in Buenos Aires, described efforts to reverse cellular aging. He highlighted U.S. company Life Biosciences’ ER‑100 therapy, which aims to restore epigenetic function and improve vision, entering early human trials with 18 participants after promising mouse results. Both initiatives seek to preserve cognitive function and restore cellular health in older adults.